Compare ARK Genomic Revolution ETF (ARKG) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Peloton Interactive Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Peloton Interactive Inc trades at $5.83 (market cap $2.54B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Peloton Interactive Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | PTON | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $9.00 |
52-Week Low | $23.09 | $3.71 |
Market Cap | — | $2.54B |
Enterprise Value | — | $3.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Peloton Interactive (PTON) trades at $5.86, down 1.35% on the day, showing signs of stabilization after a 96% decline from pandemic highs. The company reported positive operating cash flow of $333M in 2025 and is projected to achieve profitability in 2026 with $23M net income. Technical indicators show a bullish moving average trend while fundamentals reveal improving margins and declining losses, though the stock carries a high P/E ratio of 97.83. Recent developments include inclusion in the S&P SmallCap 600 index and appointment of a new CFO.
PTON presents a turnaround opportunity with improving cash flow and projected profitability, but faces significant execution risks amid declining revenue and negative shareholder equity. Analyst consensus is cautiously optimistic with a $7.50 price target representing 28% upside, though the company must demonstrate sustainable subscriber growth to justify current valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
